St James’s Centre at St Luke’s Radiation Oncology Network

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Head and neck cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• University of Birmingham1 trial
• University of Sydney1 trial

Running trials

• Active, not recruiting

  Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

  NCT04136353· Phase 3· University of Sydney· Source

• Active, not recruiting

  CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)

  NCT04116047· Phase 3· University of Birmingham· Source